IGF::OT::IGF - RESEARCH&DEVELOPMENT IN SUPPORT OF THE US ARMY MEDICAL MATERIEL DEVELOPMENT ACTIVITY (USAMMDA) FOR THE PERFORMANCE OF A PHASE I, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE LONG-TERM OPHTHALMIC SAFETY OF TAFENOQUINE VERSUS PLACEBO.

DELIVERY ORDER won by DYNPORT VACCINE COMPANY LLC
$24,654,606
RecipientDYNPORT VACCINE COMPANY LLC UEI LXNEGTYDR755
Award ID0002
Award amount$24,654,606
Award typeDELIVERY ORDER
Awarding agencyDepartment of Defense — Department of the Army
NAICS541712 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
PSCAJ53
Start dateMar 22, 2017
End dateJul 31, 2022
Place of performance—
Record updatedNov 2, 2021

View the official award record

Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.

Search open bids